TipRanks
Go Ultimate55% OFF

Kyle Malady Insider Profile

4 Followers

Kyle Malady, EVP and Group CEO-VZ Business at Verizon, holds 119.08K shares in Verizon (Ticker: VZ), holds 28.24K shares in Dexcom (Ticker: DXCM).

Kyle Malady's Trading History

VZ
Verizon
Oct 28, 2026EVP and Group CEO-VZ BusinessUninformative Sell47.30K$5.33M
DXCM
Dexcom
Jun 01, 2026DirectorUninformative Buy―$2.32M

You May Also Like

Kyle Malady insider profile FAQ

What is the percentage of profitable transactions made by Kyle Malady?
The percentage of profitable transactions made by Kyle Malady is 0%.
What is the average return per transaction made by Kyle Malady?
The average return per transaction made by Kyle Malady is -17.20%.
What stocks does Kyle Malady hold?
Kyle Malady holds: VZ, DXCM stocks.
What was Kyle Malady’s latest transaction?
Kyle Malady’s latest transaction was an Uninformative Sell of $47.30K.
What was Kyle Malady's most profitable transaction?
Kyle Malady’s most profitable transaction was an Informative Sell of VZ stock on January 29, 2025. The return on the trade was -5.50%.
What is Kyle Malady's role in Verizon?
Kyle Malady's role in Verizon is EVP and Group CEO-VZ Business.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.